"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

C Medical Technologies has closed its Series D financing round, raising gross proceeds of up to $175m. Led by Boston ...

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced today ...

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world's first living mitral ...

Zovighian said the transition to CEO has been relatively smooth since he joined Edwards in 2015 and spent eight years in ...

The treatment is an alternative to traditional open-heart surgery. The National University Heart Centre, Singapore (NUHCS) ...

NIMS Hyderabad sees surge in outpatient visits, expands capabilities with advanced procedures, research, and diagnostic services.